関連する実験動画
Updated: Feb 20, 2026

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.9K
miRNA遺伝子の変異は,通常,miRNA遺伝子の適切な機能を妨げます
Magdalena Machowska1,2, Natalia Szostak1, Adrian Tire1
1Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
Science advances
|February 18, 2026
まとめ
マイクロRNA (miRNA) 遺伝子の突然変異は,miRNAのレベルと構造を変化させ,その機能を損なう可能性があります. これらの遺伝的変化の多くが,特に病気に関連する遺伝子の多くが病原性である可能性があります.
科学分野:
- ゲノミクスゲノミクスとは
- 分子生物学は分子生物学である.
- がん研究 がん研究
背景:
- マイクロRNA (miRNA) 遺伝子を含むノンコーディングゲノム突然変異がますます確認されています.
- miRNA遺伝子変異の機能的結果と病原性は,ほとんど不明のままである.
研究 の 目的:
- miRNA遺伝子の体変異がmiRNA機能に及ぼす影響を評価する.
- これらの突然変異がmiRNAレベル,処理,前駆体安定性に与える影響を評価する.
主な方法:
- ガンゲノムアトラス (TCGA) がんサンプル>1万件を分析した.
- miRNA遺伝子の体変異を miRNA配列決定データと比較する.
- 有害な突然変異を特定するために厳格な統計基準の適用.
主要な成果:
- miRNA遺伝子変異の有意な部分は,miRNA機能に悪影響を及ぼします.
- 変異は成熟したmiRNAレベル,イソミRプロファイル (DROSHA/DICER1割れ分精度),および5p/3p鎖バランスに影響する.
- ほとんどの変異,特に有害な変異は,miRNA前駆体構造を不安定化する.
結論:
- 多くのmiRNA遺伝子変異がmiRNA遺伝子機能を損なう可能性があります.
- 病気に関連するmiRNA遺伝子の有害な突然変異は,病原性変異を代表する可能性があります.
- miRNA変異の理解は,がんゲノミクスと遺伝疾患の研究に不可欠です.
関連する概念動画
MicroRNAs
4.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs
24.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
piRNA - Piwi-interacting RNAs
7.7K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.7K
Mismatch Repair
6.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.7K
Mismatch Repair
43.9K
Overview
43.9K
RNA Interference
28.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K

